YTTRIUM Y-90 for Radioembolisation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where YTTRIUM Y-90 was used for Radioembolisation.
Most Reported Side Effects for YTTRIUM Y-90
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Abdominal pain | 17 | 12.7% | 2 | 13 |
| Off label use | 15 | 11.2% | 3 | 2 |
| Disease progression | 14 | 10.5% | 5 | 1 |
| Drug ineffective | 14 | 10.5% | 2 | 4 |
| Metastases to liver | 12 | 9.0% | 9 | 2 |
| Pyrexia | 12 | 9.0% | 1 | 11 |
| Fatigue | 11 | 8.2% | 2 | 6 |
| Thrombocytopenia | 11 | 8.2% | 4 | 2 |
| Pancreatic carcinoma metastatic | 10 | 7.5% | 3 | 0 |
| Pancreatic neuroendocrine tumour metastatic | 9 | 6.7% | 5 | 0 |
| Vomiting | 9 | 6.7% | 1 | 7 |
| Ascites | 8 | 6.0% | 2 | 7 |
| Diarrhoea | 8 | 6.0% | 2 | 3 |
| Malignant neoplasm progression | 8 | 6.0% | 7 | 0 |
| Pancytopenia | 8 | 6.0% | 5 | 3 |
Other Indications for YTTRIUM Y-90
Colorectal cancer metastatic (28)
Hepatocellular carcinoma (19)
Radiotherapy (11)
Neuroendocrine tumour (8)
Non-hodgkin's lymphoma (8)
Pancreatic neuroendocrine tumour metastatic (6)
Metastases to liver (5)